Curtis Sarah J, Jou Hsing, Ali Samina, Vandermeer Ben, Klassen Terry
Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
BMC Pediatr. 2007 Jul 18;7:27. doi: 10.1186/1471-2431-7-27.
Although sucrose has been accepted as an effective analgesic agent for procedural pain in neonates, previous studies are largely in the NICU population using the procedure of heel lance. This is the first report of the effect of sucrose, pacifier or the combination thereof for the procedural pain of venipuncture in infants in the pediatric emergency department population.
The study design was a double (sucrose) and single blind (pacifier), placebo-controlled randomized trial--factorial design carried out in a pediatric emergency department. The study population was infants, aged 0-6 months. Eighty-four patients were randomly assigned to one of four groups: a) sucrose b) sucrose & pacifier c) control d) control & pacifier. Each child received 2 ml of either 44% sucrose or sterile water, by mouth. The primary outcome measure: FLACC pain scale score change from baseline.
crying time and heart rate change from baseline.
Sucrose did not significantly reduce the FLACC score, crying time or heart rate. However sub-group analysis revealed that sucrose had a much greater effect in the younger groups. Pacifier use reduced FLACC score (not statistically significant), crying times (statistically significant) but not heart rate. Subgroup analysis revealed a mean crying time difference of 76.52 seconds (p < 0.0171) (0-1 month) and 123.9 seconds (p < 0.0029) (1-3 month). For subgroup age > 3 months pacifier did not have any significant effect on crying time. Age adjusted regression analysis revealed that both sucrose and pacifier had significant effects on crying time. Crying time increased with both increasing age and increasing gestational age.
Pacifiers are inexpensive, effective analgesics and are easy to use in the PED for venipuncture in infants aged 0-3 months. The benefits of sucrose alone as an analgesic require further investigation in the older infant, but sucrose does appear to provide additional benefit when used with a pacifier in this age group.
Current Controlled Trials ISRCTN15819627.
尽管蔗糖已被公认为新生儿程序性疼痛的有效镇痛剂,但以往研究主要针对新生儿重症监护病房(NICU)中足跟采血操作的人群。这是首篇关于蔗糖、安抚奶嘴或两者联合使用对儿科急诊科婴儿静脉穿刺程序性疼痛影响的报告。
本研究设计为双盲(蔗糖)和单盲(安抚奶嘴)、安慰剂对照的随机试验——析因设计,在一家儿科急诊科开展。研究对象为0至6个月的婴儿。84名患者被随机分为四组之一:a)蔗糖组;b)蔗糖与安抚奶嘴组;c)对照组;d)对照与安抚奶嘴组。每个孩子经口接受2毫升44%蔗糖溶液或无菌水。主要结局指标:FLACC疼痛量表评分相对于基线的变化。
哭闹时间和心率相对于基线的变化。
蔗糖并未显著降低FLACC评分、哭闹时间或心率。然而,亚组分析显示,蔗糖在较年幼组中的效果要大得多。使用安抚奶嘴可降低FLACC评分(无统计学意义)、哭闹时间(有统计学意义),但对心率无影响。亚组分析显示,0至1个月组平均哭闹时间差异为76.52秒(p < 0.0171),1至3个月组为123.9秒(p < 0.0029)。对于年龄大于3个月的亚组,安抚奶嘴对哭闹时间无显著影响。年龄校正回归分析显示,蔗糖和安抚奶嘴对哭闹时间均有显著影响。哭闹时间随年龄和胎龄的增加而增加。
安抚奶嘴是廉价、有效的镇痛剂,在儿科急诊科用于0至3个月婴儿静脉穿刺时易于使用。单独使用蔗糖作为镇痛剂对较大婴儿的益处需要进一步研究,但在此年龄组中,蔗糖与安抚奶嘴联合使用时似乎确实能提供额外益处。
当前受控试验ISRCTN15819627 。